Arrowstreet Capital’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.3M | Buy |
+735,417
| New | +$20.3M | 0.01% | 685 |
|
|
2025
Q1 | – | Sell |
-22,453
| Closed | -$444K | – | 1913 |
|
|
2024
Q4 | $444K | Sell |
22,453
-139,190
| -86% | -$2.75M | ﹤0.01% | 1578 |
|
|
2024
Q3 | $4.04M | Buy |
161,643
+21,582
| +15% | +$539K | ﹤0.01% | 1028 |
|
|
2024
Q2 | $2.62M | Sell |
140,061
-45,752
| -25% | -$854K | ﹤0.01% | 1006 |
|
|
2024
Q1 | $3.67M | Buy |
185,813
+109,061
| +142% | +$2.15M | ﹤0.01% | 978 |
|
|
2023
Q4 | $1.35M | Buy |
76,752
+4,037
| +6% | +$70.8K | ﹤0.01% | 1046 |
|
|
2023
Q3 | $1.26M | Buy |
+72,715
| New | +$1.26M | ﹤0.01% | 940 |
|